Week 305 Review - Yet another bad week but 4D Pharma starts to recover

I guess this is renowned as a bad time of year for share price value, but it's depressing when every time you claw some back, the following week it vanishes again. The deficit between cost and value widened by £3,342 this week to £31,206 and the portfolio value fell to £115,540. The crumb of comfort was that I cashed in a bit more profit.

The worst performer was JLP:Jubilee Metals which fell 30% of my purchase price, but at 327% up it's still my best performing share.

CAML:Central Asia Metals also had a bad week dropping 9%, and the few I sold this week were at an even lower price than that. They are still 42% up, but I've decided to reduce my holding a little as although it's a great company, the recent tailings dam leak shows that mining stocks are always risky and it's best to diversify. They still make up 2.5% of my portfolio, down from about 8% before I started selling. I may stop selling them now.

CMCL:Caledonia Mining dropped 6% in a bad week for all my mining stocks.

Share of the Week was the only significant riser. DDDD:4D Pharma climbed 10% but are still 17% down. I'm hoping this is the start of the recovery though.

I think for next week I can adjust this chart to start at £75K. The flat green line is deceptive due to the increases in both injection and cost.

This is a true reflection of the abject misery I'm feeling.

Here's the ISA and shares portfolio after week 45 of year 6.

			Weekly Change
Cash	£39.08		-£3.75
Portfolio cost	£70,691.67		+£0
Portfolio sell value (bid price-commission)	£55,984.74	(-20.8%)	-£1,720.61
Potential profits	£7,074.08		-£650.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£6,218.52		+£0
Yr 6 projected avg monthly profit	£594.85	(16.3%)	-£13.89
Total Dividends	£1,343.15		+£0
Total Profit from sales	£26,645.13		+£0
Average monthly cash profit	£393.75	(10.8%)	-£1.35
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	63%		+0%

Potential profits fell by £650 thanks to the drop in JLP:Jubilee Metals, but the rest of the portfolio dropped by an additional £1,000 thanks to OPTI:Optibiotix falling yet again. Long term performance is still above target.

Back to being closer to injection than cost.

At least this one is still just above the low of 3 weeks ago.

The SIPP looks like this after week 289 overall and week 29 of year 6.

			Weekly Change
Cash	£207.19		-£101.18
Portfolio cost	£73,175.51		+£379.63
Portfolio sell value (bid price - commission)	£57,550.91	(-21.4%)	-£1,691.57
Potential profits	£1,590.30		-£684.03
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,491.30		+£295.11
Yr 6 projected avg monthly profit	£1,232.53	(33.8%)	-£0.93
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£22,950.74		+£295.11
Average monthly cash profit	£377.17	(10.3%)	+£2.88
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+1%

Potential profits dropped by £684 as only CAML:Central Asia Metals and FXPO:Ferrexpo are in profit now. Fortunately most of my new magic formula shares are only down a few percent, so I'm hoping they will be in profit once spread and commission have cleared. Overall value fell further, mainly thanks to the drop in OPTI:Optibiotix.

The £295 (39.7%) profit was from selling another 400 shares in CAML:Central Asia Metals for 259.33p. I used the proceeds to buy 2,242 share in OPTI:Optibiotix costing £1,112.89. That takes me above 160,000 shares, so I think I really ought to stop now.

Long term performance remains above target, although will fall below target once the next pension transfer injection comes through. The absolutely great news is that my bond fund has increased enough to take me over the minimum £2,200 required to do a transfer this month. I just need to wait a few days for the payment to make it into the account, and then the 10 days it takes to transfer. If DDDD:4D Pharma stays around 100p I'll buy more of that, else magic formula shares. SBTX:SkinBioTherapeutics is still way to expensive to buy.

Even this is getting to the point where it is almost as close to the orange line as the red.

Total disaster - the worse it's been for 12 months.

The trading account looks like this after week 255 overall and week 47 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,499.04	(-36.9%)	+£69.73
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£62.52	(31.6%)	-£1.39
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.03	(8.6%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

A good week thanks to DDDD:4D Pharma climbing 10%. It would have been better if the others hadn't dropped in value. Almost at the end of year 5 and no prospect of selling anything else this year. It will still be a record performance. 

A rare tick upwards!

My only hope is news from DDDD:4D Pharma as everything else is stuck in a hole.

Late writing my blog again this week, so nothing more to pontificate about.